Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Drugs in MeSH Category Angiotensin II Type 1 Receptor Blockers

Email this page to a colleague

« Back to Dashboard

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sciegen Pharms Inc	VALSARTAN	valsartan	TABLET;ORAL	204038-001	Oct 27, 2021	AB	RX	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Mylan	VALSARTAN	valsartan	TABLET;ORAL	090866-003	Jan 5, 2015	AB	RX	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Square Pharms Ltd	VALSARTAN	valsartan	TABLET;ORAL	205347-002	Apr 9, 2018	AB	RX	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Inventia	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	208659-001	May 18, 2020		DISCN	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Prinston Inc	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	091497-001	Jun 6, 2011	AB	RX	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Teva	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	076958-002	Apr 6, 2010		DISCN	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
Alkem Labs Ltd	VALSARTAN	valsartan	TABLET;ORAL	205536-004	Mar 12, 2019	AB	RX	No	No	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial				⤷ Sign up for a Free Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

AstraZeneca

Baxter

Colorcon

Dow

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.